FibroGen Ord Shs
KYNB9.220USD
-0.280-2.95%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Company
FibroGen Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of FibroGen Ord Shs
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Currency: USDUpdated: Fri, Jan 9
Currency: USDUpdated: Fri, Jan 9
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
26.11M
88.16%
Europe
6.27M
21.17%
China
91.00K
0.31%
Japan - Related Party
-2.85M
-9.64%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.34%
The Vanguard Group, Inc.
4.55%
Acadian Asset Management LLC
2.73%
BlackRock Institutional Trust Company, N.A.
2.08%
Marshall Wace LLP
1.79%
Other
79.51%
Shareholders
Shareholders
Proportion
Armistice Capital LLC
9.34%
The Vanguard Group, Inc.
4.55%
Acadian Asset Management LLC
2.73%
BlackRock Institutional Trust Company, N.A.
2.08%
Marshall Wace LLP
1.79%
Other
79.51%
Shareholder Types
Shareholders
Proportion
Hedge Fund
11.65%
Investment Advisor
9.61%
Investment Advisor/Hedge Fund
6.73%
Individual Investor
1.66%
Research Firm
0.22%
Other
70.14%
Institutional Shareholding
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
179
1.13M
28.01%
-541.82K
2025Q4
191
1.14M
28.21%
-565.81K
2025Q3
217
1.14M
28.21%
-598.21K
2025Q2
270
1.07M
26.59%
-1.31M
2025Q1
333
1.37M
33.84%
-1.29M
2024Q4
342
1.50M
37.30%
-1.40M
2024Q3
352
1.88M
46.81%
-1.29M
2024Q2
365
2.27M
57.18%
-1.02M
2024Q1
367
2.47M
62.50%
-1.25M
2023Q4
366
2.83M
72.07%
-821.61K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Armistice Capital LLC
378.00K
9.34%
+42.00K
+12.50%
Sep 30, 2025
The Vanguard Group, Inc.
184.24K
4.55%
+6.20K
+3.48%
Sep 30, 2025
Acadian Asset Management LLC
110.28K
2.73%
-28.84K
-20.73%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
84.04K
2.08%
--
--
Sep 30, 2025
Marshall Wace LLP
72.45K
1.79%
+149.00
+0.21%
Sep 30, 2025
PRIMECAP Management Company
58.88K
1.46%
-30.82K
-34.36%
Sep 30, 2025
Geode Capital Management, L.L.C.
43.68K
1.08%
-354.00
-0.80%
Sep 30, 2025
Two Sigma Investments, LP
40.22K
0.99%
+26.11K
+185.01%
Sep 30, 2025
Hightower Advisors, LLC
39.75K
0.98%
--
--
Sep 30, 2025
Renaissance Technologies LLC
29.28K
0.72%
+18.10K
+161.88%
Sep 30, 2025
View more
Related ETFs
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Name
Proportion
Proshares Ultra Russell 2000
0%
iShares Russell 3000 ETF
0%
Invesco NASDAQ Future Gen 200 ETF
0%
Invesco RAFI US 1500 Small-Mid ETF
0%
ProShares Hedge Replication ETF
0%
Fidelity Enhanced Small Cap ETF
0%
Global X Aging Population ETF
0%
iShares Micro-Cap ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
View more
Proshares Ultra Russell 2000
Proportion0%
iShares Russell 3000 ETF
Proportion0%
Invesco NASDAQ Future Gen 200 ETF
Proportion0%
Invesco RAFI US 1500 Small-Mid ETF
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
Fidelity Enhanced Small Cap ETF
Proportion0%
Global X Aging Population ETF
Proportion0%
iShares Micro-Cap ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of FibroGen Ord Shs?
The top five shareholders of FibroGen Ord Shs are:
Armistice Capital LLC holds 378.00K shares, accounting for 9.34% of the total shares.
The Vanguard Group, Inc. holds 184.24K shares, accounting for 4.55% of the total shares.
Acadian Asset Management LLC holds 110.28K shares, accounting for 2.73% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 84.04K shares, accounting for 2.08% of the total shares.
Marshall Wace LLP holds 72.45K shares, accounting for 1.79% of the total shares.
Armistice Capital LLC holds 378.00K shares, accounting for 9.34% of the total shares.
The Vanguard Group, Inc. holds 184.24K shares, accounting for 4.55% of the total shares.
Acadian Asset Management LLC holds 110.28K shares, accounting for 2.73% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 84.04K shares, accounting for 2.08% of the total shares.
Marshall Wace LLP holds 72.45K shares, accounting for 1.79% of the total shares.
What are the top three shareholder types of FibroGen Ord Shs?
The top three shareholder types of FibroGen Ord Shs are:
Armistice Capital LLC
The Vanguard Group, Inc.
Acadian Asset Management LLC
Armistice Capital LLC
The Vanguard Group, Inc.
Acadian Asset Management LLC
How many institutions hold shares of FibroGen Ord Shs (KYNB)?
As of 2026Q1, 179 institutions hold shares of FibroGen Ord Shs, with a combined market value of approximately 1.13M, accounting for 28.01% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -0.20%.
What is the biggest source of revenue for FibroGen Ord Shs?
In FY2024, the -- business generated the highest revenue for FibroGen Ord Shs, amounting to -- and accounting for --% of total revenue.
